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EVALUATION OF A NOVEL LIGHT-EMITTING DIODE  
DEVICE FOR PRODUCING VITAMIN D 
AJAY KUMAR RAVICHANDRAN 
ABSTRACT 
Vitamin D is a fat-soluble hormone essential for humans as it is a key player in 
calcium and phosphorus homeostasis for bone mineralization, and is linked to many 
nonskeletal health outcomes such as autoimmune diseases and cardiovascular disease as 
well.  The primary source of vitamin D is the conversion of 7-dehydrocholestrol (7-
DHC), which naturally exists in the plasma membranes of skin cells, to previtamin D3 by 
the exposure to the ultraviolet-B (UV-B) portion of sunlight.  Despite humans’ ability to 
cutaneously synthesize vitamin D, many factors limit this process, and consequently 
vitamin D deficiency has become a common medical issue worldwide.  Deficient 
individuals may not respond well to traditional vitamin D replacement through dietary 
supplementation if suffering from fat malabsorption syndromes while unable to get 
sufficient vitamin D from sun exposure due to location, sunscreen use, or cultural 
practices, among other reasons.   
It has been previously reported that exposure to artificial sources of UV-B 
radiation (UV lamps, tanning beds, among others) produces cutaneous vitamin D, but 
heat generation, poor portability, and other inconveniences to the deficient patient limit 
therapeutic use of these devices.  In addition, broad-spectrum sources of UV radiation 
reduce the production of vitamin D compared to narrow-band sources because of the 
photoequilibrium that is established.  The advent of the light-emitting diode (LED) 
	  	   viii 
provided a compact, energy-efficient, high-intensity, low-heat alternative radiation 
source, and the recent development of the UV LED offers a viable alternative for 
developing a personalized vitamin D-producing device.   
 
This thesis presents evidence that UV LEDs have the capacity to efficiently 
synthesize vitamin D3 in vitro and in human skin.  Ampoules of 7-DHC were irradiated in 
triplicate with LEDs at 280, 285, 290, 295, 298, 300, and 310 nm.  The 298 nm LED was 
found to have the most efficient previtamin D3 production of 7.0% in vitro at the 
equivalent of 0.75 minimal erythemal dose (MED, rated at 1 MED = 32 milliJoules per 
centimeter squared for type II skin), compared to all other assessed LEDs.  Irradiation of 
human skin samples (IRB-exempt) with the 298 nm diode (~39 seconds of radiation) 
indicated that 1.5% of the original 7-DHC in type II (Caucasian) skin could be converted 
to vitamin D3 in situ after exposure to 0.75 MED.  These results imply that manufacturing 
a cuff containing 298 nm LEDs that covers 3.8% of the total surface area of skin could 
provide 600 IUs of vitamin D3 if operated for just 39.0 seconds.  The data provide a 
promising new approach to treat vitamin D-deficient patients suffering from fat 
malabsorption syndromes. 
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INTRODUCTION 
Evolutionary Perspective of Vitamin D 
 Vitamin D, the “sunshine vitamin”, is potentially the oldest hormone in existence, 
supported by the discovery of some of the earliest phytoplankton species on earth can 
make vitamin D from natural stores of ergosterol when exposed to sunlight.  While the 
reasons for vitamin D production in nonvertebrates are not yet fully understood, it likely 
plays a key role in survival.1  In fact, ergosterol and its photoproducts efficiently absorb 
ultraviolet-B (UV-B) radiation at wavelengths between 280-315 nanometers (nm) which 
are capable of damaging deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and 
proteins.  As a result, ergosterol likely developed to act as a natural sunscreen to protect 
the organism from the harmful radiation.2  
 Calcium is essential for healthy bone mineralization in the skeletal structure of 
vertebrates.  As evolution proceeded, organisms left the calcium-rich oceans to explore 
land, where calcium was only available in plants that could extract it from the soil.  To 
adapt to their calcium-poor surroundings and maintain skeletal health, they needed to 
increase the efficiency of intestinal calcium absorption from dietary plant sources.  
Vitamin D evolved to fulfill this role.3  When these early land-dwelling organisms were 
exposed to sunlight on their skin, provitamin D3 (7-dehydrocholesterol or 7-DHC) and/or 
ergosterol in their plasma membranes converted to vitamin D.  For reasons not well 
understood, this photosynthetic process became responsible for modulating calcium 
absorption. Today, most land-dwelling species require sunlight for vitamin D production, 
especially humans.2,3 
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Vitamin D Sources 
 While there are multiple forms of vitamin D, the predominant forms are D2 and 
D3 (derived from ergosterol and 7-DHC, respectively), referring to differences in side 
chain structure (Fig. 1).  7-DHC is the principal precursor for cutaneous synthesis in 
animals; it exists in human skin, where it is converted to vitamin D3 upon exposure to 
sunlight.  This being said, the primary source of vitamin D is exposure to sunlight.4,5  
   
  Fig. 1.  Structures of vitamin D2 and D3 and their respective precursors, 
  ergosterol and 7-DHC.  Both forms of vitamin D differ only by their side chain  
structures. Reproduced from (21). 
 
Very few foods are natural sources of vitamin D.  These include salmon, 
mackerel, herring, and other oily fish.  Mushrooms and yeast contain ergosterol, which 
converts to previtamin D2 upon UV-B irradiation.  Vitamin D3 used in food fortification 
can be synthesized from lanolin and added to select foods including milk, cheese, yogurt, 
and cereals.3-6  Supplemental forms (as solutions, injections, and dietary capsules) of 
Tobetter definewhetherphytoplankton could
photosynthesizevitaminD,Holicketal. [1982a];
Holick [1989] grew 100 L of Emiliania huxlei
(an organism that has existed unchanged in the
Sargasso sea for at least 750 million years) and
Skeletonema menzelii in pure culture to a cell
density of 106 cells perml in glass carboys in the
absence of ultraviolet B (UVB) radiation. The
cells were harvested by centrifugation, resus-
pended in synthetic sea water, and 50% of the
cells were transferred into a quartz vessel and
exposed to simulated solarultraviolet radiation.
3H-7-dehydrocholesterol was added to the cells
before they were extracted with diethylether
for recovery determinations and the lipid ex-
tracts were chromatographed on a straight
phase high performance liquid chromotograph
(HPLC). The ultraviolet absorbing peak was
analyzed bymass spectroscopy anddemonstrat-
ed an apparent molecular ion of 396 suggest-
ing that the major component was ergosterol
(Fig. 1). Th cell that were expos to UVB
radiation demonstrated a marked reduction in
ergosterol and the appearance of previtamin D2
(Fig. 2) that was confirmed by mass spectro-
scopy. The amount of ergosterol inE. huxleiwas
1.0 mg of ergosterol/g wet weight. S. menzelii
was also found to photosynthesize vitamin D2
from ergosterol [Holick et al., 1982a,b; Holick,
1989].
An evaluation of plankton net tows from the
Sargasso sea revealed a wide variety of pro-
vitamin D’s. Brine shrimp and krill were lipid
extracted and an HPLC analysis showed sev-
eral provitamin D’s, including 7-dehydro-
cholesterol, ergosterol, and other unidentified
provitaminD’s.Uponexposure tosimulated sun-
light, both krill and brine shrimp converted
their provitamin D’s to their respective pre-
vitamin D’s [Holick et al., 1982a; Holick, 1989].
Brine shrimp and krill contained 82 and 74% of
their total provitamin D content as 7-dehydro-
cholesterol.
Although the function of provitamin D is not
known in either phytoplankton or zooplankton,
there are at least three possible functions based
on the provitamin D’s ability to absorb UVB
radiation. Since theUVabsorption spectrum for
provitamin D, previtamin D, and vitamin D
completely overlap the UV absorption spectra
for DNA, RNA, and proteins, it is possible that
the provitamin D evolved as a natural sun-
screen to protect the UV sensitive macromole-
cules from solar ultraviolet radiation damage
(Fig. 3). Another possible function is that every
time provitamin D was converted to a photo
product the organism recognized this as a
photochemical signal that related to the amount
of ultraviolet radiation it was exposed to.
Provitamin D, which is structurally rigid and
sandwiched inbetweenthe fattyacidside chains
and polar head group [Tian et al., 1999] in the
plasma membrane, has its ring opened upon
exposure to ultraviolet radiation; this could
have resulted in an alteration in membrane
permeability to enhance the entrance of cations
such as calcium into the cell.
Bills [1924] evaluated the vitamin D content
of over 100 different species of fish and found a
wide range of vitamin D activity from as high as
45,000 IU/g of oil in oriental tuna to less than
1 IU/g in gray sole liver oil and sturgeon liver oil.
Bills [1927] was unable to demonstrate that
when catfish were exposed to high intensity
ultraviolet radiation they increased their anti-
rachitic activity in their viseral oils. Sea water
absorbs most of the high energy ultraviolet
radiation within the first few meters and,
therefore, if marine fish were to make vitamin
D in the skin they would need to be exposed to
sunlight near the surface of the sea. However,
the question remained as to whether fish had
the capacity to produce vitamin D in their skin.
Fish skin was exposed to ultraviolet radiation
Fig. 1. Structure of vitamin D3 and D2 and their respective
precursors, 7-dehydrocholesterol, and ergosterol. The only
structural difference between vitamin D2 and D3 is in their side
chains; the side chain for vitamin D2 contains a double bond
between C-22 and C-23 and a C-24 methyl group. (Reproduced
with permission) [MacLaughlin and Holick, 1983].
Vitamin D 297
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vitamin D2 and D3 are available as well.5  Both vitamin D2 and D3 are equally effective in 
maintaining vitamin D levels.2,3   
 
Photobiology of Vitamin D 
 
Fig. 2.   The 
photoconversion of 
provitamin D3 (or 7-
DHC) to vitamin D3 
upon exposure to the 
UV-B portion of 
sunlight. The plasma 
membrane’s 
importance is 
emphasized, 
showing that it 
stabilizes the S-cis,S-
cis-previtamin D3 
conformer, which is 
the only conformer 
that can thermally 
isomerize to vitamin 
D3.  Adapted from 
(10). 
 
7-DHC naturally exists in the plasma membranes of epidermal keratinocytes and 
dermal fibroblasts of human skin.4-6 7-DHC will absorb UV-B photons upon exposure to 
sunlight, causing the cleavage of the C9–C10 bond in the B ring and thereby forming a 
9,10-seco-steroid, S-cis,S-cis-previtamin D3.3,7  This photolytic product is 
thermodynamically unstable and subsequently undergoes a rearrangement of double 
bonds to form the stable vitamin D3.1-7  Interestingly, the cell membrane is critical for 
cutaneous vitamin D production.  The S-cis,S-cis conformer of previtamin D3 (preD3) is 
energetically unstable and isomerizes to the S-trans,S-cis conformer in vitro; however, 
only the S-cis,S-cis conformer can thermally isomerize to vitamin D3.  In situ human skin 
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studies reveal that hydrophilic and van der Waals interactions in the phospholipid bilayer 
of the cell membrane stabilize the S-cis,S-cis conformer so it does not become S-trans,S-
cis (Fig 2), indicating the importance of the cell membrane for vitamin D3 production.3   
Evidence indicates that skin has a very large capacity to produce vitamin D; in a 
bathing suit (nearly 100% of the surface area of the body), exposure to enough sunlight 
that causes a minimal erythemal dose (MED) generates enough vitamin D equivalent to 
orally consuming at least 10,000 international units (IU).8  Thus, exposure of 1% of the 
body can provide 100 to 250 IUs of vitamin D3.  Any alterations to the cutaneous 
presence of 7-DHC will influence photosynthesis of vitamin D.1-4,8  Previous findings 
show that the amount of 7-DHC in skin declines with age.  In fact, a 70 year-old 
individual will make one-fourth of the vitamin D that a 20 year-old individual would 
make with the same amount of sun exposure.2-4,6,8  Cutaneous production also varies 
based on the ability of UV-B photons to penetrate the skin.4-8  Melanin, the body’s 
natural sunscreen which absorbs UV-B, is present in higher quantities in heavily 
pigmented individuals.  Because melanin can “compete” with 7-DHC for absorption of 
UV-B photons, individuals with darker skin require a greater time of sun exposure to 
synthesize a comparable amount of vitamin D to their lighter-skinned counterparts.5-8  
Sunscreens serve to protect skin from UV radiation and, when applied, will absorb UV-B 
before skin can.6-9  A sunscreen with a sun protection factor of 8 (SPF-8) absorbs 92-95% 
of UV-B, therefore diminishing the capacity for vitamin D synthesis.1,3  Given that only 
the UV-B portion of sunlight is responsible for producing vitamin D, the solar zenith 
angle is also an important determinant.6-9  When the sun is directly above us in the 
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summer at noontime, 1-5% of solar UV-B radiation is able to reach the surface; as the 
solar zenith angle becomes more oblique with changes in latitude, season, and time of 
day, this amount decreases because more UV-B is absorbed by the ozone layer, 
diminishing the capacity for cutaneous vitamin D synthesis.  This accounts for the 
minimization of vitamin D production during the early morning before 10 AM and in the 
afternoon after 3 PM, and in the winter above 37° North and below 37° South latitudes.2  
If the ozone layer does not absorb UV-B, pollution can.  Vitamin D deficiency is 
prevalent in areas of widespread pollution, especially in large cities. 
Prolonged sun exposure cannot produce excessive vitamin D3, because any preD3 
or D3 that remains in skin and does not reach circulation will absorb solar UV radiation 
and isomerize to several biologically inactive photoproducts.  Upon UV absorption, 
excess vitamin D3 isomerizes to suprasterol I or II, or 5,6-transvitamin D3, while excess 
preD3 isomerizes to tachysterol3 and lumisterol3 (Fig. 3A).9,10  MacLaughlin et al. 
demonstrated that when 7-DHC is converted to preD3 upon exposure to sunlight in a 
light-skinned Caucasian, the amount of preD3 reaches a plateau after about 15 minutes 
and a subsequent rise in tachysterol3 and lumisterol3 is observed.10,11  The production of 
preD3 and these photoisomers is dependent on the wavelength of UV radiation,11 due to 
differences in the UV absorption characteristics of each.  The optimal wavelengths for 
preD3 production are between 295 and 300 nm, with a maximum around 297 nm (Fig. 
3B).10,12  In situ studies revealed that human skin exposed to narrow-band radiation at 
295±5 nm can yield a maximum conversion to preD3 of 60±5 percent of the original 
concentration of 7-DHC, while tachysterol and lumisterol were about 25 and 5 percent 
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Fig. 3.  (A) Photosynthesis, photoisomerization, and photodegradation of vitamin D3 from 7-DHC. (B) The 
action spectrum of preD3 formation from 7-DHC in human skin.  Note that PreD3 formation reaches an 
apparent maximum around 297-298 nm. Adapted from (10) and (11). 
 
respectively.11,12  Interestingly, simulated solar radiation only results in a maximum of 15 
to 20 percent, while tachysterol and lumisterol were at 3 to 6 and 50 to 60 percent 
respectively, suggesting that the spectral character of sunlight may influence the 
photosynthesis of vitamin D.11,12  These studies suggest that narrow-band radiation could 
potentially be an ideal substitute for sun exposure, especially for individuals who may 
have limited sun exposure and/or intestinal malabsorption preventing supplementation.  
 
A	  
B	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Metabolism of Vitamin D 
 Vitamin D2 and vitamin D3 are biologically inert until activated.  Once vitamin D2 
is ingested or vitamin D3 synthesized in the skin, it is drawn into the dermal capillary bed 
by the vitamin D binding protein (DBP) and enters circulation.12  It travels to the liver 
where it is converted to 25-hydroxyvitamin D [25(OH)D], the major circulating form of 
vitamin D assayed to determine vitamin D status.13,14  25(OH)D is biologically inert, so it 
travels to the kidneys where it is metabolized to the active form 1,25-dihydroxyvitamin D 
[1,25(OH)2D] by the enzyme 25-hydroxyvitamin D-1α-hydroxylase (CYP27B1).13,14  
The renal production of active vitamin D is controlled by serum parathyroid hormone 
(PTH), calcium, and phosphate levels.13,14 
Upon activation, 1,25(OH)2D travels in the circulation to its vitamin D receptor 
(VDR) in target tissues that regulate calcium and phosphate homeostasis.14-16 In the 
intestine, the interaction of vitamin D with its VDR enhances the expression of an 
epithelial calcium channel, thereby increasing intestinal absorption of calcium; it also 
stimulates phosphate absorption.14-17  The interaction also increases phosphorus 
absorption and the expression of other proteins that enhance calcium absorption, like 
calbindin9k.16-17  When 1,25(OH)2D interacts with its VDR in skeletal osteoblasts, it 
increases the expression of RANKL (receptor activator of NFκB ligand), which interacts 
with the RANK receptor of monocytic preosteoclasts and induces the formation of 
mature osteoclasts that act to release calcium from bone.17  In the kidneys, 1,25(OH)2D 
acts to increase calcium reabsorption.  Finally, 1,25(OH)2D regulates PTH production by 
negative feedback in the parathyroid glands.13-17  In all, the major physiologic function of 
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vitamin D is the regulation of calcium and phosphorus homeostasis, not only for skeletal 
health but for many other metabolic functions in the body.  VDRs are present in 
numerous tissues not involved in calcium and phosphorus metabolism18,19, and although 
vitamin D action is only understood for a few tissues, this broadens the scope for other 
possible actions of vitamin D.   
 
Vitamin D Deficiency and Health Consequences 
 Today, vitamin D deficiency is considered a worldwide pandemic, with an 
estimated prevalence of upwards of 50% deficient individuals in North America, Europe, 
Asia, New Zealand, and Australia.3,4,6  Ample exposure to unpolluted sunlight could 
fulfill humans’ vitamin D requirement.  However, the advancement of civilization and the 
Industrial Revolution leading to extensive pollution blocking human exposure to UV-B 
has made vitamin D a dietary necessity, and this brought about the emergence of 
widespread deficiency.20  Given that vitamin D is classically associated with the 
development of a healthy skeleton, severe deficiency results in poor bone mineralization, 
causing rickets in children and osteomalacia in adults.  Deficiency has also been linked to 
the development of secondary hyperparathyroidism, as well as a greater risk of 
fracture.19,21  However, VDRs are found in many tissues not involved in calcium and 
phosphate metabolism (e.g. the heart, brain, pancreas, and immune cells, among 
others),21-23 suggesting the potential health consequences of vitamin D deficiency extend 
much further than skeletal health.  Mutations in the VDR gene have been associated with 
the risk of developing cardiovascular disease, cancer, type 1 diabetes mellitus, and 
	  9 
immune disorders.21-25  In fact, VDR ligands, mainly 1,25(OH)2D, induced 
antiproliferative, prodifferentiative, and immunomodulatory effects in clinical and 
experimental settings,21 and these effects may not be possible without sufficient 
25(OH)D.  
There has been considerable debate over the precise definition of vitamin D 
deficiency, but the Institute of Medicine (IOM) suggests that according to existing 
literature, a serum concentration of 20 ng/mL is adequate for skeletal health.19-21  On the 
other hand, the Endocrine Society Practice Guidelines indicate that 20 ng/mL is the 
threshold for deficiency, between 21 and 29 ng/mL is for insufficiency, and 30 ng/mL is 
for sufficiency, citing the latter as the threshold to reap all potential benefits of vitamin 
D.21,24  The IOM, however, has not changed their recommendation on the grounds that 
there is insufficient evidence supporting extraskeletal benefits of vitamin D.19,21  For this 
thesis, a circulating 25(OH)D less than 20 ng/mL will be used as the standard indicating 
deficiency. 
 There are a host of possible causes for vitamin D deficiency.  As mentioned 
earlier, factors that affect either 7-DHC content or the amount of UV-B radiation 
penetrating the skin will modulate cutaneous synthesis of vitamin D3: age, increased 
melanin content, sunscreen, solar zenith angle, and clothing.1-8,25  Interestingly, there is a 
high prevalence of osteomalacia and rickets in Saudi Arabian women and children, 
respectively, likely spurred by cultural traditions of clothing the entire body.26,27  The 
bioavailability of vitamin D supplementation is also modulated by several factors.  The 
use of certain medications, including bile acid sequestrants, antiseizure medications, and 
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glucocorticoids, can decrease bioavailability.28,29  Obesity yields low bioavailability as 
well; serum 25(OH)D level negatively correlates with body mass index (BMI) and body 
fat content, likely due to fat deposits acting as “sinks” for the fat-soluble vitamin D.30,31  
Studies have also revealed that patients with intestinal/fat malabsorption syndromes, such 
as Crohn’s disease, Whipple’s disease, and cystic fibrosis, are also at high risk for 
deficiency, likely for similar reasons.32,33  Major causes and health outcomes of vitamin 
D deficiency are pictorially represented in Figure 4. 
 
Figure 4.  Major causes of vitamin D deficiency and health consequences.  Reproduced from (23). 
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Potential Use of UV Light-Emitting Diodes for Vitamin D Deficiency 
 Taking into account the many determinants of efficient cutaneous synthesis 
ranging from location to cultural practices, exposure to sunlight may not provide 
adequate vitamin D for many individuals who have limitations to cutaneous synthesis.  
While dietary supplementation could serve a viable substitute for these situations, 
individuals with intestinal malabsorption syndromes or taking certain medications may 
not be able to effectively extract vitamin D from dietary sources.  In these instances, UV 
phototherapy could enhance cutaneous synthesis of vitamin D, especially in the winter 
months when vitamin D photoproduction is low.  In fact, in 1919, Huldschinsky 
demonstrated that rickets could be cured by exposure to sunlight or artificial sources of 
UV radiation.  After mounting evidence in the following years, it became widely 
accepted that vitamin D requirements for skeletal health could be fulfilled by artificial 
UV exposure.34  Broad-spectrum UV-B radiation mimicking the UV-B range of sunlight 
(280-320 nm) is recommended in the treatment of vitamin D deficient psoriasis, but 
25(OH)D levels are attenuated compared to supplementation35, likely because the 
spectral character of sunlight is shown to decrease the potential for cutaneous synthesis 
compared to narrow-band radiation.11,35 In fact, supplemental vitamin D increased the 
blood level of 25(OH)D by 74% compared to the broad-spectrum radiation at 36%.35  A 
pilot study of an 8-week tanning lamp phototherapy for patients with malabsorption 
syndromes showed increases in vitamin D levels, but the results were suboptimal,36 likely 
for similar reasons.  This again indicates that narrow-band radiation could be a better 
candidate for artificial radiation-based cutaneous production of vitamin D. 
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 Light-emitting diodes (LEDs) are narrow-band artificial light sources that have 
gained considerable attention in recent years for their high efficiency, long lifetime, and 
low heat production compared to incandescent or fluorescent lighting.37  Visible LEDs 
are already used for a variety of lighting applications, but the production of a blue or UV 
LED was significantly more difficult until Akasaki, Amano, and Nakamura found that 
gallium nitride crystals were pivotal for stable UV emission in 1992, for which they 
received the Nobel Prize in Physics in 2014.37  UV LEDs have since found relevance in 
water purification, disinfection of medical tools, and medical diagnostics.38  Beyond these 
existing applications, UV LEDs could be used to enhance the skin’s naturally immense 
capacity for synthesizing vitamin D.  Such an application could be especially useful for 
vitamin D deficient individuals with malabsorption syndromes and unable to get 
sufficient sun exposure. 
 
Goals of this Thesis 
 Vitamin D deficiency is already considered a pandemic, spurred by the many 
factors limiting the cutaneous synthesis of vitamin D3.  Patients with fat malabsorption 
are at an especially high risk for deficiency because the effectiveness of vitamin D 
replacement by way of dietary supplementation is significantly attenuated.  Treatments 
using artificial UV-B exposure enhance cutaneous synthesis of vitamin D3 for these 
patients, but these sources of radiation suffer from energy inefficiency, poor portability, 
and other issues.  UV LEDs do not have many of these limitations and can therefore 
serve as efficient devices that enhance the synthesis of vitamin D3 in skin.  The primary 
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goal of this thesis was to evaluate and characterize the effect of UV LEDs that emit 
different wavelengths on the production of previtamin D3 in vitro and in situ.  Based on 
the in vitro data, the best LED candidate was used to determine the potential for vitamin 
D synthesis in situ.  The evaluation of these diodes will serve as a benchmark for future 
manufacturing of LED-based devices such as a portable, removable cuff that can be used 
for the treatment and prevention of vitamin D deficiency in patients with fat 
malabsorption syndromes.  
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MATERIALS AND METHODS 
 
Materials 
Crystalline 7-DHC (Fluka Biochemika, HPLC-grade) was dissolved in ethanol 
(Fisher Scientific, HPLC-grade) and diluted to a concentration of 50 µg/mL.  Clear glass 
ampoules (Wheaton, 2 mL, pre-scored) were filled with 250 µL of this solution, sealed 
with Parafilm, and stored in a -80°C freezer for use throughout the project. 
Human skin samples were obtained at random from surgical procedures (IRB-
exempt approval) at Boston Medical Center’s Department of Plastic Surgery.  Samples 
within the same skin type were from the same patient, but information on patient 
characteristics was not known.  Samples were organized by traditional skin pigment 
classification (Type II – Caucasian, Type III – Indian, Type IV – African American). 
Samples were stored in a -80°C freezer immediately after they were obtained.   
Diodes with peak wavelengths of 280, 290, 295, 300, and 310 nm (all ± 5 nm) 
were purchased from Sensor Electronic Technology, Inc (SETi).  An additional LED with 
a peak wavelength of 285 nm (± 5 nm) was obtained from the Boston University 
Photonics Lab, and another with a peak at 298 nm (± 5 nm) was obtained from DOWA 
Electronic Materials Company, Ltd.  All LEDs had a maximal current of 20 milli-
Amperes (mA).  All LEDs were powered by a current-limiting power source (Boston 
University Photonics Lab) to ensure the current did not exceed 20 mA, regardless of the 
voltage applied. 
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High-pressure liquid chromatography (HPLC) is a method that separates 
compounds on the basis of polarity.  Because of this, the photoproducts of 7-DHC and 
their photoisomers have different retention times on the HPLC columns, allowing for 
effective separation.  In this study, separation was achieved using an HPLC system 
(Agilent, 1100 Series) equipped with a variable wavelength detector.  A UV response at 
265 nm was used to quantify preD3 and vitamin D3, while a response at 280 nm was used 
to quantify 7-DHC, tachysterol3, and lumisterol3. 
HPLC-grade solvents such as isopropyl alcohol (IPA), ethyl acetate (EtAc), and 
hexane obtained from commercial sources (Acros, American Bioanalytical, and Fisher 
Scientific, respectively) were used to prepare the mobile phases used in the HPLC 
analysis. 
 
In vitro Irradiation of 7-DHC Ampoules and Separation of Photoproducts 
 7-DHC ampoules were positioned such that the bottom of the ampoule was 
consistently kept 5.0 mm above the LED light source (Figure 5).  The MED output of 
each LED was measured with a SolarMeter® Digital UV Radiometer (Solartech, Inc.) 
measuring MEDs/hr at a distance of 5.0 mm.  The specifications of this digital meter 
rated 1 MED/hr as equivalent to 21 milliJoules per cm2 (mJ/cm2).  Ampoules were 
irradiated for 1, 3, 5, 10, and 25 minutes (repeated measures with three ampoules of the 
same 7-DHC solution per time point), and LEDs were operated at a constant maximal 
current of 20 mA.   
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Fig. 5.  Picture of (A) an ampoule containing 7-DHC placed on the (B) LED setup, along 
with (C) the power source equipped with (D) a current-limiting resistor. 
 
 
 After irradiation, the contents of the 7-DHC ampoules were transferred to test 
tubes.  The samples were dried under nitrogen gas, re-dissolved in 140 µL of 0.8% IPA in 
hexane, and transferred to auto-sampler vials.  The samples then underwent single 
normal-phase HPLC analysis using a silica stationary phase column (Agilent ZORBAX 
Rx-SIL, 5 µm pore size, 4.6 x 250 mm), and a mobile phase of 0.8% IPA in hexane with 
a flow rate of 1.5 mL/min achieved separation of photoproducts.  The UV detector set at 
265 nm was used to detect the presence of previtamin D3, 7-DHC, tachysterol3, and 
lumisterol3.  Integration of the peaks provided areas under the curve (AUC) for these 
photoproducts whenever present.  The amount of each photoproduct was determined by 
comparing AUCs to standard curves.  From this data, the percent conversion of 7-DHC to 
preD3 and other photoproducts was determined.   
A	  
B	  
C	  
D	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In situ Irradiation of Human Skin Samples and Separation of Photoproducts 
Based on the results from the in vitro phase, skin samples were irradiated with the 
UV LED with the greatest efficiency for producing preD3.  As shown in Table 1, this was 
determined to be the 298 nm LED. Type II, III, and IV skin samples (obtained from BMC 
Dept. of Plastic Surgery, IRB-exempt) were positioned upside-down 5.0 mm above the 
diode (over a hole in a platform with an area of approximately 0.45 cm2) ensuring the 
outer epidermal layer was exposed to the radiation (Figure 6).  Samples for each type 
were from the same patient.  Samples were irradiated for 5 and 10 minutes.  
Unfortunately, repeated measures could not be performed for skin due to lack of sample 
availability.	  	  
Fig. 6.  Aerial view of 
(A) the LED centered 
beneath a hole on the 
platform, and (B) type 
IV skin positioned 
upside-down on the hole 
0.5 cm above the diode, 
such that a 0.385 cm2 
area of the epidermal 
layer was exposed. 
 
 
After irradiation, a 0.385 cm2 circular area of the exposed area of the epidermis of 
each sample was biopsied using a circular brass punch with a diameter of 0.70 cm.  The 
biopsied piece was immersed in a water bath at 60°C to cleave the epidermal layer at its 
interface with the dermal layer.  The epidermis was mechanically scraped off with a 
sterile scalpel and placed in a test tube containing 8.0% EtAc in hexane.  The contents of 
the test tube were subjected to pulsed sonication for 10 seconds to ensure that the 
B	  A	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EtAc/hexane solution extracted the 7-DHC and its photoproducts.  The test tubes were 
then capped and placed in a 60°C water bath and incubated for a minimum of 16 hours to 
convert any preD3 to vitamin D3.  This step was added because vitamin D3 migrated later, 
thus there was less interference from other lipids that were present in the skin.   
After incubation, the EtAc containing the 7-DHC and its photoproducts was 
removed from the skin pellet of each sample.  These solutions were dried under nitrogen 
gas, re-dissolved in 0.3% IPA in hexane, and transferred to autosampler vials.  The 
samples were then separated using single normal-phase HPLC analysis, with a 
cyanopropyldimethylsilane stationary phase column (Agilent ZORBAX CN, 5 µm pore 
size, 4.6 x 250 mm), and a 0.3% IPA in hexane mobile phase at a flow rate of 1.0 
mL/min.  UV detection at 265 nm confirmed the presence of vitamin D3, 7-DHC, 
tachysterol3, and lumisterol3.  Integration of the peaks provided AUCs for these 
photoproducts whenever present.  The concentration of each photoproduct was 
determined by comparing AUCs to standard curves.  From this data, the percent 
conversion of 7-DHC to vitamin D3 in situ was determined. 
Statistical Analyses 
 For the in vitro phase of this study, a series of two-tailed student’s t tests were 
used to establish statistical significance between the LED with the highest production of 
preD3 (and other photoproducts) and all other LEDs at each time point of irradiation.  
Two-tailed student’s t tests also compared the percent conversion of 7-DHC to preD3 at 
0.75 MED for the 298 nm LED to the percent conversions of each of the other assessed 
wavelengths.  A p-value less than 0.05 was considered to be statistically significant.  
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Two-tailed student’s t tests were conducted using VassarStats (a free statistics calculator 
available online at http://vassarstats.net). 
 Due to limited sample availability, repeated measures with skin samples could not 
be conducted, and only preliminary skin data is reported.  As a result, statistical analyses 
could not be performed for the in situ phase of the study. 
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RESULTS 	  
   For the first phase of the study, the efficiency of UV-B LEDs at various 
wavelengths for producing preD3 in vitro was assessed.  As samples passed through the 
HPLC column, a UV detector set to 265 nm confirmed the presence of preD3, lumisterol3, 
tachysterol3 and 7-DHC.  A representative chromatogram, obtained after irradiating an 
ampoule at 295 nm for 10 minutes and containing the peaks of all four compounds, is 
shown in figure 7.  The UV absorption spectra for preD3, tachysterol3, lumisterol3, and 7-
DHC are shown in figure 8.         
         A             B            C D 
 
Fig. 7.  A representative chromatogram detected at 265 nm of  (A) preD3, (B) lumisterol3, (C) tachysterol3, 
and (D) 7-DHC, obtained in this study after irradiating an ampoule at 295 nm for 10 minutes.  
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Fig. 8.  The UV absorption spectra obtained for each 
photoproduct.  (A) is the spectrum for preD3, (B) is for 
tachysterol3, (C) is for lumisterol3, and (D) is for 7-DHC. 
 
The primary aim of the in vitro phase of this study was to characterize the 
photoconversion of 7-DHC to its various photoproducts at various wavelengths as a 
function of time. All of the LEDs were capable of producing preD3.  As originally 
predicted based on the action spectrum of preD3 formation (Figure 3B), the 298 nm LED 
produced the maximum amount of preD3 after 25 minutes (52.5±0.5%).  Interestingly, 
however, the time-response curve of each wavelength had markedly different 
characteristics.  The 280, 285, and 290 nm LEDs quickly reached a maximum percent 
conversion of 7-DHC to preD3 between 35-45% in approximately 5 minutes, after which 
A	   B	  
D	  C	  
Absorb
ance	  (m
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no additional production was seen with greater irradiation time (Figure 9).  The 295, 298, 
and 300 nm LEDs exhibited more gradual increases in percent conversion of 7-DHC to 
preD3 over time.  The 295 and 298 nm LEDs resulted in ~40% after approximately 8 and 
15 minutes, respectively (Fig. 9).  The 300 nm LED resulted in less than 30% conversion 
to preD3 after 25 minutes, while the 310 nm LED barely reached 1% (Fig. 9). 
 
Fig. 9.  The production of preD3 over time (shown as mean ± standard error of the mean (SEM) 
based on triplicate measurements) for each wavelength is depicted.  The 280 nm LED resulted in 
a significantly higher conversion than all other LEDs at 3 minutes, while the 290 nm LED 
resulted in significantly higher conversion at 10 minutes, and the 298 nm LED resulted in 
significantly higher conversion, after 25 minutes (two-tailed student’s t tests used to compare 
LED with the highest conversion at a particular time point against all other LEDs at the same 
time point, p < 0.01 for all points indicated by an (*) asterisk). 
 
Photoproducts of preD3 were also observed in vitro, and their amounts at various 
times changed based on the wavelength of irradiation.  The varied production of these 
photoproducts provides insight into the differences in the photoequilibrium of each 
assessed wavelength.  Tachysterol3 was the major photoproduct observed when preD3 
production began reaching photoequilibrium, peaking at 55.8±0.5% for the 280 nm 
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diode, and its production appeared to reduce with increasing wavelength (Fig. 10A).  
Lumisterol3 was minimally produced for all the LEDs, but its production mimicked the 
wavelength-dependent variations in preD3 production, significantly higher at 298 nm 
(3.2±0.1%) than the other wavelengths (Fig. 10B).  As shown in figure 11, the 
comparison of the production of preD3 and its photoproducts between all LEDs revealed 
that tachysterol3 production gradually increased and continued to increase when preD3 
production reached a plateau.  This is especially apparent for the 280, 285, and 290 nm 
LEDs.  PreD3 quickly reached maximal level within 5 minutes, after which preD3 was 
converted to tachysterol3.  
 
Fig. 10.  The percent conversion of 7-DHC to (A) tachysterol3 and (B) lumisterol3 in vitro over 
time (each point is shown as mean ± SEM derived from triplicate measurements) with LEDs of 
different wavelengths.  The LED with the greatest production of tachysterol3 or lumisterol3 at a 
particular time point is indicated by an asterisk (*) (two-tailed student’s t tests comparing LED 
with the highest production at a particular time point against all other LEDs at the same time 
point, p < 0.01 for all).   
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Fig. 11.  The percent of 
original 7-DHC 
converted to PreD3, 
lumisterol3, and 
tachysterol3 (shown as 
mean ± SEM derived 
from triplicate 
measurements). Each 
panel (A-G) is for a 
different LED 
(wavelengths specified).    
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The minimal erythemal dose (MED) output for each of the LEDs must be 
considered when selecting the best LED candidate for producing vitamin D.  For type II 
skin (Caucasian), one MED is defined as the amount of UV-B radiation that causes a 
uniform slight pinkness to the skin 24 hours after exposure.  According to the FDA, the 
recommended amount of UV exposure for tanning should not exceed 0.75 MED per day, 
thus a promising LED candidate should be able to synthesize the greatest amount of 
preD3 in vitro in the least amount of time it takes to reach 0.75 MED.  To determine this, 
the MEDs per hour output of each LED were measured using a SolarMeter® Digital UV 
Radiometer (Solartech, Inc.).  Because the specifications of this digital radiometer rated 1 
MED as 21 mJ/cm2 (type I skin), the MEDs/hr reading was adjusted to be consistent with 
the 32 mJ/cm2 per 1 MED rating for type II skin.  MEDs/hr was inversely proportional to 
increasing wavelength (Figure 12), indicating that lower wavelengths required less 
exposure time to cause erythema.   
 
Fig. 12.  MEDs/hr measured with a digital UV radiometer as a function of wavelength. 
MEDs/hr was adjusted from a rating of 21 mJ/cm2 per MED to 32 mJ/cm2 per MED. 
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The MEDs/hr reading and the in vitro results described in Figure 9 were used to 
approximate the time required of each LED to reach an exposure of 0.75 MED (24 
mJ/cm2 for type II skin).  The percent conversion of 7-DHC to preD3 at 0.75 MED for 
each sample was estimated based on the initial linear trend in percent conversion to preD3 
for each individual sample, and the mean and standard error of the mean (SEM) for each 
LED were calculated.  These results are tabulated in Table 1.  Exposure to the 298 nm 
LED resulted in the highest average percent conversion of 7-DHC to preD3 at 0.75 MED 
compared to any of the other LEDs that were evaluated.  Two-tailed student’s t tests were 
used to compare the estimated average percent conversion at 0.75 MED of the 298 nm 
LED against each of the other LEDs.  Using a significance level of 0.05, the 298 nm LED 
displayed a significantly higher percent conversion of 7.0 ± 0.3% at 0.75 MED compared 
to all other diodes. A graphical interpretation of this data, showing the variation of 
average preD3 production at 0.75 MED for each wavelength, is shown in Figure 13. 	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Wavelength  
(nm) 
MEDs/hour Time (secs)  
to 0.75 
MED 
% conversion to 
preD3 at 0.75 
MED 
p-value 
280 128.0 21.0 5.6 ± 0.3 < 0.01 
285 125.0 21.6 5.5 ± 0.7 < 0.01 
290 106.2 25.8 6.0 ± 0.3 0.02 
295 70.7 38.4 3.7 ± 0.1 < 0.01 
298 69.9 39.0 7.0 ± 0.3 Reference 
300 49.2 55.2 2.1 ± 0.1 < 0.01 
310 4.9 553.8 0.5 ± 0.1 < 0.01 
Table 1.  The estimated percent conversion of 7-DHC to preD3 for each assessed wavelength in vitro after 
exposure to 0.75 MED of radiation.  MEDs/hr has been adjusted from the instrumental rating of 21 mJ/cm2 
per MED to 32 mJ/cm2 per MED for Type II skin.  Percent conversion is shown as mean ± SEM based on 
triplicate measurements for each wavelength.  Two-tailed student’s t tests were used to determine the 
statistical significance of the LED with the highest production of preD3 (here, the 298 nm LED) compared 
to each of the other LEDs (p-values indicated). 
 
 Fig. 13.  Average percent conversion to preD3 (from 7-DHC) in response to 0.75 MED (rated to 
1 MED = 32 mJ/cm2 for type II skin).  Bars are shown as means ± SEM, constructed based on the 
initial linear trends of percent conversion to preD3 from the in vitro results, as well as MEDs/hr 
data for each LED. The asterisk (*) indicates the LED with the highest percent conversion to 
preD3 at 0.75 MED (two-tailed student’s t test, p< 0.01). 
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Since the 298 nm LED was the most efficient in producing preD3 in vitro after 
exposure to 0.75 MED, it was used for the in situ phase with skin samples.  A 
representative chromatogram of type II skin irradiated with the 298 nm LED for 10 
minutes, along with the UV absorption spectrum for vitamin D3, is shown in Figure 14.   
 
Fig. 14.  (A) A 
representative 
chromatogram of type II 
skin irradiated with the 298 
nm LED for 10 minutes.  
Peaks for vitamin D3, 
tachysterol3, and 7-DHC are 
labeled.  (B) The UV 
absorption spectrum of 
vitamin D3. 
 
 
0.385 cm2 biopsies of Type II (Caucasian), III (Indian), and IV (African-
American) skin samples irradiated with the 298 nm LED for 10 minutes resulted in 
15.5%, 10.0%, and 4.0% of 7-DHC being converted to preD3 (detected as vitamin D3), 
respectively (Figure 15).  This result indicates that greater irradiation time is required to 
make the same amount of preD3 in darker skin compared to lighter skin.  The percent 
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conversion of 7-DHC to preD3 after exposure to 0.75 MED for type II skin was estimated 
based on the initial trend in preD3 production from 0 to 5 minutes.  These calculations 
indicate that after ~39.0 seconds, 1.5% of the original 7-DHC could be converted to 
preD3 in type II skin.  A minimal amount of tachysterol3 was observed after 5 minutes for 
type II and III skin and 10 minutes for type IV skin (Fig. 16).  No other photoproducts 
were observed. Due to limited availability of skin samples, the in situ phase of this study 
could not be done in triplicate, thus no statistical analyses were performed for these 
preliminary data.   
 
 
 
Fig. 15.  The percent conversion of 7-DHC to preD3 (detected as vitamin D3) for skin types II, III, 
and IV after irradiation with the 298 nm LED.  Two samples for each skin type (both from the 
same patient) were available for use, one of which was irradiated for 5 minutes, and the other for 
10 minutes.  0.385 cm2 biopsies of the irradiated area were subjected to HPLC analysis. Due to 
the limited availability of skin samples, measurements could not be done in triplicate, thus bars 
shown are single measurements (no mean or SEM could be calculated). 
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Fig. 16.  The percent conversion of 7-DHC to tachysterol3 for skin types II, III, and IV after 
irradiation with the 298 nm LED.  Two samples for each skin type (both from the same patient) 
were available for use, one of which was irradiated for 5 minutes, and the other for 10 minutes.  
0.385 cm2 biopsies of the irradiated area were subjected to HPLC analysis.  Due to the limited 
availability of skin samples, measurements could not be done in triplicate, thus bars shown are 
single measurements (no mean or SEM could be calculated). 
 
  
0.0	  1.0	  
2.0	  3.0	  
4.0	  5.0	  
6.0	  7.0	  
5	  minutes	   10	  minutes	  %	  
Co
nv
er
si
on
	  o
f	  7
-­‐D
H
C	  
to
	  T
ac
hy
st
er
ol
3	  
Time	  (minutes)	  
Type	  II	  Type	  III	  Type	  IV	  
	  31 
DISCUSSION 
 
 Vitamin D is responsible for a wide range of metabolic effects, although primarily 
associated with calcium and phosphorus homeostasis and healthy bone mineralization.2-6  
Vitamin D deficiency is one of the most common medical issues today, classically 
associated with skeletal deformities including rickets in children and osteomalacia in 
adults.19,21  Deficiency is also related to cardiovascular disease, type 1 diabetes mellitus, 
and cancer, among other issues unrelated to skeletal health.21-25  Humans’ primary source 
of vitamin D is naturally occurring, caused by the photoconversion of cutaneous stores of 
7-DHC to preD3 after exposure to UV-B photons in sunlight.1-6  Despite skin’s immense 
capacity for synthesizing vitamin D3, there are a number of key determinants for the 
efficiency and effectiveness of photosynthesis: wavelength of radiation, age, season, 
latitude, time of day, pollution, sunscreen use, cultural clothing practices, and skin color, 
to name a few.1-8,25-27 Correcting deficiency by restoring healthy vitamin D status is 
complicated by these factors influencing cutaneous synthesis, as well as intestinal 
malabsorption of dietary vitamin D caused by Crohn’s disease, Whipple’s disease, cystic 
fibrosis, and gastric bypass surgery.32,33  Individuals residing in areas with limited UV-B 
exposure who are also unable to absorb dietary vitamin D are at high risk for deficiency, 
and replacement by supplementation or sensible sun exposure may not suffice.  
Huldschinsky found that exposure to a mercury arc lamp cured rickets,34 eventually 
leading to UV phototherapy as a suitable option for enhancing cutaneous synthesis of 
vitamin D.  However, current phototherapeutic UV radiation sources suffer from a 
number of setbacks, including low efficiency of conversion of 7-DHC to preD3, high 
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energy consumption, heat generation, and being at an exact distance from the UV 
radiation source, all of which can pose problems to the vitamin D-deficient patient.  
 LEDs are a class of semiconductors that serve as compact, high-efficiency, low-
energy consuming, long-lasting alternative light and radiation sources.37  That being said, 
LEDs are increasingly used in place of traditional lighting (e.g. incandescent and 
fluorescent bulbs, among others) for a wide variety of applications.  In fact, the advent of 
the UV LED gave rise to uses in water purification, disinfection, and medical 
diagnostics.38  However, current phototherapeutic methods for vitamin D replacement do 
not yet use LED technology.  This study indicates that narrow-band UV-B LEDs can 
efficiently convert 7-DHC to preD3 in vitro and in situ, thereby offering a possible 
alternative radiation source for efficient vitamin D3 synthesis.  Based on the results, UV 
LEDs could be much more effective for phototherapy not only because of their compact, 
high-intensity, low-energy nature, but also because their narrow-band radiation has been 
shown in this study to optimize preD3 production.  This confirms a previous observation 
that narrow-band radiation was much more effective in producing preD3 compared to 
broad-spectrum radiation.11  The results obtained show that LEDs of 280, 285, 290, 295, 
298, 300, and 310 nm were all effective in converting 7-DHC to preD3.  However, 
considering that lower wavelengths in the UV-B range (280-290 nm) are more damaging 
to DNA and RNA in skin,2 higher wavelengths still capable of photosynthesizing preD3 
are preferred.  Another health concern for UV phototherapy is minimizing the number of 
photons that can cause a minimal erythemal dose.  The Food and Drug Administration 
currently recommends no more than 0.75 MED per day for tanning.  According to the 
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data, MEDs per hour decreases with increasing wavelength, indicating the LEDs at 
higher wavelengths could be better candidates for cutaneous synthesis of vitamin D with 
less potential for causing erythema and skin damage thereby improving the benefit-to-
risk ratio.  Based on the results, the 298 nm LED yielded the greatest photoconversion of 
7-DHC to preD3 compared to other wavelengths after exposure to 0.75 MED (Table 1), 
converting an average of 7.0% of the original 7-DHC content to preD3 in vitro.  This is 
consistent with findings by MacLaughlin et al, who reported that UV-B radiation around 
297-298 nm resulted in optimal preD3 production, as shown in the action spectrum for 
preD3 formation in Figure 3B.11  Along the same lines, it was interesting to note that the 
295 nm LED consistently converted significantly less 7-DHC to preD3 (3.7 ± 0.1%) after 
0.75 MED than the 280, 285, or 290 nm LEDs (5.6 ± 0.3%, 5.5 ± 0.7%, and 6.0 ± 0.3% 
respectively).  This result is not in accordance with the action spectrum, possibly due to 
variations in the spectral output of this particular LED.  Further studies, including the 
characterization of the spectral output of the LEDs, will need to be conducted to better 
understand the reason for this inconsistency. 
Given the in vitro results, the 298 nm LED was used to determine its effectiveness 
in producing vitamin D3.   Type II, III, and IV skin irradiated for 10 minutes showed 
15.5, 10.0, and 4.0% conversion of 7-DHC to preD3 (detected as vitamin D3).  This result 
clearly shows that individuals with more pigmented skin will take longer to cutaneously 
produce the same amount of vitamin D3 compared to those with less pigment, consistent 
with the idea that melanin competes with 7-DHC to absorb UV-B.5-8  Because the 
MEDs/hour readings were adjusted for type II skin, the results of the type II skin 
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irradiations were used to determined that exposure to 0.75 MED (or 24 mJ/cm2) of 
radiation could convert approximately 1.5% of the original 7-DHC content to preD3.  It 
has been previously reported that exposure of an adult body in a bathing suit (nearly 
100% of the body’s surface area) to one MED of simulated sunlight can produce 10,000-
20,000 IUs of vitamin D3,8 thus 0.75 MED can theoretically produce up to 15,000 IUs.  
The average surface area of skin on an adult is 15,000 cm2, thus 0.75 MED of sunlight 
should be able to produce up to 1.0 IU, or 25.0 ng, of vitamin D3 per cm2 of exposed skin.  
A young adult has approximately 1750 ng of 7-DHC per cm2 of skin,39 and factoring in 
that 0.75 MED of simulated sunlight can produce 25.0 ng of vitamin D3 per cm2, this 
comes to approximately 1.4% conversion.  The time of sunlight exposure required to 
cause 0.75 MEDs can be greater than 20 minutes depending on skin type, while the 298 
nm LED requires only 39.0 seconds.  Taking all of this together, the results indicate that a 
298 nm LED can produce vitamin D3 in skin with a much greater efficiency than 
sunlight, converting 1.5% of 7-DHC to preD3.  The IOM currently recommends 600 IUs 
per day of dietary vitamin D to maintain sufficiency in adults.  If multiple 298 nm LEDs 
could be put together to cover 3.8% of the average surface area of skin (570.0 cm2), 
exposure to the collective radiation for 39.0 seconds could produce approximately 600 
IUs (or 15,000 ng) of vitamin D3 in a young adult, fulfilling their vitamin D requirement 
for that day. 
The data obtained in this study is especially important for individuals with 
malabsorption syndromes.  Given the vast number of aforementioned factors influencing 
natural cutaneous synthesis of vitamin D by sunlight, vitamin D supplementation is now 
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practically a necessity.  Patients with fat malabsorption syndromes caused by Crohn’s 
disease, Whipples disease, cystic fibrosis, and gastric bypass surgery, among other 
causes, will not efficiently absorb the fat-soluble vitamin D and are thus at higher risk for 
developing deficiency.  For such individuals, a method of enhancing cutaneous 
photosynthesis of preD3 is necessary to sustain vitamin D status.  Traditional methods of 
UV phototherapy suffer from a number of setbacks including energy inefficiency, and 
thus UV LEDs could overcome many of those issues.   
In conclusion, these preliminary results evaluated the effectiveness of UV LEDs 
for producing vitamin D3.  A cuff or blanket containing UV LEDs could be manufactured 
for use by vitamin D deficient patients with malabsorption syndromes to induce the 
cutaneous synthesis of vitamin D3.  Based on these findings, if the cuff covers 3.8% of 
the body and is operated for approximately 39 seconds per day, a patient could fulfill 
their daily vitamin D requirement (as defined by the IOM).  Because lack of skin sample 
availability for the in situ phase in this study, repeated measures will be necessary in the 
future to increase confidence in the in situ results obtained.  If patient data can be 
collected for future skin samples, this could offer even more confidence in the results by 
adjusting for various factors (age, BMI, etc.).  Before a cuff or blanket can be 
manufactured, more data needs to be collected on the precise intensity of UV-B radiation 
required for optimal synthesis while minimizing the risk of harmful effects.  
Characterizing the spectral output of LEDs will be the next step to achieving this.  
Nonetheless, this study strongly indicates that UV LEDs have immense potential as a 
new treatment method for vitamin D deficiency.  
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